Capstan Stock
Capstan Therapeutics is a biotechnology company advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or under-served clinical need.
Sign up for SecondMarket™ to view the market and buy or sell Capstan Stock
Buy + SellCapstan Funding
Sign up to gain insights into Capstan funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Mar 05, 2024 | Series B | 87.50M | ||
| Jun 14, 2022 | Series A | 76.50M | ||
| Nov 24, 2021 | Series Seed | 63.00M |
See Capstan Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Capstan Stock Valuation + Share Prices
View real-time Tape D™ data on Capstan stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Capstan Management Team
Capstan Major Investors
Learn More About Capstan Stock
Buy Capstan Stock
01Sell Capstan Stock
02Capstan Stock Price
03Capstan Stock Ticker Symbol
04Criteria to Sell Capstan Stock
05Criteria to Buy or Invest in Capstan Stock
06Capstan Stock Settlement
07Capstan IPO
08*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
Sign up for SecondMarket™ to view the market and buy or sell Capstan Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
